IP Library Granted Patent US 11,103,669
Granted Patent B2
US 11,103,669 · App. 14/948,992 · Granted Aug 31, 2021

Nitric oxide therapies

Inventor: David H. Fine (Cocoa Beach, FL)
Assignee: Vero Biotech LLC
A61M16/12A61K31/655A61K33/00A61K47/02A61M5/165A61M15/00A61M15/08A61M15/085A61M16/105A61M35/006A61K9/0043A61K9/0073A61K9/7023A61M2005/006A61M2202/0275A61M2205/75
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,103,669
App. No.
14/948,992
Granted
Aug 31, 2021
Kind
B2
Abstract

A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.

Claims (23)

1. An apparatus, comprising:

an air inlet;

an outlet configured to be positioned at at least one of a nose or a mouth of a user;

a chamber between the inlet and the outlet through which air flows from the inlet to the outlet;

a porous solid matrix disposed in the chamber and constructed by sintering a polymeric resin; and

a silica gel disposed in pores of the porous solid matrix, the silica gel including an antioxidant.

2. The apparatus of claim 1 , wherein the antioxidant is at least one of ascorbic acid, alpha tocopherol, or gamma tocopherol.

3. The apparatus of claim 1 , wherein the air inlet, the outlet and the chamber each have a width, wherein the width is measured in a direction perpendicular to the longitudinal axis of the breathing device, and the width of the chamber is greater than the width of the inlet or outlet.

4. The apparatus of claim 1 , wherein the inlet, outlet and chamber are cylindrical, and the diameter of the chamber is greater than the diameter of the inlet or the diameter of the outlet.

5. The apparatus of claim 1 , further comprising a a nitric-oxide releasing agent disposed in the chamber.

6. The apparatus of claim 1 , further comprising a nitric oxide-releasing agent disposed in the chamber.

7. The apparatus of claim 1 , further comprising a nitric oxide-releasing biopolymer disposed in the chamber.

8. The apparatus of claim 1 , further comprising:

a moisture-proof container, the chamber disposed in the moisture-proof container, the silica gel configured to be activated before use by removing the chamber from the moisture-proof container and exposing the silica gel to water.

9. An apparatus, comprising:

a cartridge;

a porous solid matrix disposed within the cartridge;

an antioxidant disposed within the cartridge; and

a polymeric nitric oxide-releasing agent disposed within the cartridge.

10. The apparatus of claim 9 , further comprising a silica gel disposed within pores of the porous solid matrix, the silica gel containing the antioxidant.

11. The apparatus of claim 9 , further comprising:

a moisture-proof container, the chamber disposed in the moisture-proof container, the silica gel and the antioxidant configured to be activated before use by exposing the cartridge to water.

12. The apparatus of claim 9 , wherein the porous solid matrix is constructed of sintered thermoplastic.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Aug 7, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 048173/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2016
From: FINE, DAVID
To: GENO LLC
Reel/Frame 039270/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2016
From: FINE, DAVID H.
To: GENO LLC
Reel/Frame 039270/0308 →
Cited By (1)
US 12,661,477